Table 1

 Mortality in relation to risk variables by univariable and multivariable analyses* in the non-invasive cohort

Risk variableFulfilling risk variable criteriaMortality risk variableUnivariable analysesMultivariable analyses (n = 1157)
PresentAbsentOR (95% CI)p ValueOR (95% CI)p Value
*Hosmer-Lemeshow test, χ2 = 2.8, p = 0.73; †median value; ‡troponin T ⩾0.03 µg/l or, if not available, troponin I ⩾0.03 µg/l; §interleukin 6 (IL-6) ⩾5 ng/l or, if not available, C reactive protein (CRP) ⩾10 mg/l.
BMI, body mass index; CI, confidence interval; MI, myocardial infarction; NA, not applicable; OR, odds ratio.
Age ⩾70 years382/1235 (30.9%)6.8%2.6%2.76 (1.54 to 4.93)0.0012.18 (1.17 to 4.07)0.014
Male sex834/1235 (67.5%)4.2%3.2%1.31 (0.68 to 2.50)0.42NANA
BMI ⩾26 kg/m2671/1218 (54.2%)3.7%3.8%0.97 (0.54 to 1.75)0.92NANA
Cholesterol ⩾5.8 mmol/l†588/1194 (49.2%)3.1%4.5%0.88 (0.48 to 1.60)0.62NANA
Hypertension377/1235 (30.5%)6.4%2.8%2.36 (1.32 to 4.22)0.009NA0.15
Diabetes144/1235 (11.7%)12.5%2.7%5.05 (2.74 to 9.32)<0.0014.18 (2.17 to 8.04)<0.001
Previous MI268/1235 (21.7%)6.7%3.1%2.25 (1.23 to 4.10)0.008NA0.055
Angina pectoris >3 months428/1235 (34.7%)5.6%3.0%1.94 (1.09 to 3.46)0.025NA0.18
ST depression at entry572/1215 (47.1%)5.8%2.0%2.96 (1.54 to 5.69)0.0012.54 (1.29 to 5.00)0.007
Increased troponin‡828/1188 (69.7%)4.5%2.5%1.82 (0.87 to 3.82)0.11NANA
Fibrinogen ⩾3.8 g/l†617/1169 (52.8%)4.9%2.7%1.83 (0.97 to 3.44)0.061NANA
IL-6 ⩾5 or CRP ⩾10§326/1176 (27.7%)8.3%2.4%3.75 (2.07 to 6.78)<0.0013.26 (1.75 to 6.09)<0.001